FindTrial
Sign In

A study to campare various blood investigations in COVID-19 positive patients.

Comparison of prognostic value of various Inflammatory markers (Interleukin-6, Procalcitonin, D-Dimer, CRP and Ferritin levels) in COVID-19 positive adult patients in Intensive care units.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026800
Enrollment
72
Registered
2020-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Max Superspeciality Hospital Vaishali
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients ( >18 years) admitted to the ICU who are RT-PCR confirmed covid-19 positive cases. 2.Adult patients ( >18 years) admitted to the ICU who are COVID-19 Antigen positive cases.

Exclusion criteria

Exclusion criteria: The following will be excluded from the ambit of the study: 1. Pregnant patients. 2. When prolonged antibiotic therapy is indicated (e.g., infective endocarditis, tuberculosis etc). 3. Patients with estimated length of stay less than 24 hours. 4. Severely immuno compromised patients (e.g., patients with HIV and a CD4 count 5. Patients who are bedridden with chronic multiorgan diseases.

Design outcomes

Primary

MeasureTime frame
To compare the role of INTERLEUKIN-6, PROCALCITONIN, D-DIMER, CRP and FERRITIN in terms of mortality at 28 days in confirmed covid-19 patients.Timepoint: 28 days—

Secondary

MeasureTime frame
Comparison of these inflammatory markers levels with mortality at 7 days. - Comparison of these inflammatory marker levels with duration of mechanical ventilation requirement/mechanical ventilation free days. - To study the correlation between organ failure severity and level of these inflammatory markers. - To study the correlation between levels of these inflammatory markers and total days in ICU and in hospital. Timepoint: 7 days—

Countries

India

Contacts

Public ContactDr Dhananjay Batwara

Max Superspeciality Hospital Vaishali

dhananjay_batwara@yahoo.com9099058184

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026